People · Operator
Named in public records as an officer, director or promoter · active 2008–2018 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ionix Medical Inc. | — | Other Technology | Series B | $20.2M | $558.3M | 2008 |
| Chitogen Inc | — | Biotechnology | Seed | $3.9M | $6.9M | 2018 |
Kai Kroll at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kai Kroll on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Levy | 1 | 6 |
| James Drake | 1 | 2 |
| Michael Patrick Reilly | 1 | 1 |
| James Franklin Drake | 1 | 1 |
| Yong Hua Zhu | 1 | 1 |
| Yong Zhu | 1 | 1 |
| Steve Muellerleile | 1 | 1 |
| Frederick Albright | 1 | 1 |
| Douglas Eayrs | 1 | 1 |
| Albert Emola | 1 | 1 |
| Donald Sturtevant | 1 | 1 |
| David Adinolfi | 1 | 1 |
| Phillips Smith | 1 | 1 |
| Douglas Alan Eayrs | 1 | 1 |
| Mark Kroll | 1 | 1 |
| Donald L Sturtevant | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.